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Introduction. Population-based cancer registries provide vital information for planning, prevention 
and cancer management. Information generated by the registries must be comprehensive, valid and 
comparable. Because of their importance, regular quality assessments are recommended. 
Objective. The quality of cancer incidence data were assessed at four population-based cancer 
registries in Colombia for cancer incidence estimations.
Material and methods. Data collected at population-based cancer registries of Bucaramanga, Cali, 
Pasto, and Manizales were included. Completeness was assessed by the use of graphs in illustrating 
the mortality incidence ratios and their relation to the survival. Validity was evaluated by the description 
of morphologically verified cases, cases identified from death certificates only, and the internal 
consistency of the data. 
Results. There was a global under-coverage of cancer registration at Bucaramanga and Manizales, 
whereas a more specific under-coverage for certain localizations was observed in Cali and Pasto. 
Validity analyses established that death certificates were little used as a source of information, and 
some inconsistencies appeared among the data associated with the most valid basis of diagnosis and 
morphology. 
Conclusions. In Colombia, the data quality at population-based cancer registries can be further 
improved by considering the use of additional sources of information, such as death certificates, the 
use of specialized software for data capture, and automatic validation of internal consistency. Mortality 
certification must be improved in areas where a population-based cancer registry is operating.
Key words: vital statistics, neoplasms, quality control, data collection, reproducibility of results, 
Colombia.
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Calidad de los datos en los registros de cáncer de base de población en Colombia
Introducción. La información de los registros de población de cáncer resulta de vital importancia en 
la planeación, prevención y manejo del cáncer. La información generada por los registros debe ser 
exhaustiva, válida y comparable, por lo que se recomienda hacer evaluaciones periódicas de calidad.
Objetivo. Evaluar algunos aspectos relacionados con la exhaustividad y la validez de la información 
recolectada por los registros de población de cáncer en Colombia para estimar las cifras de cáncer en 
el país.
Materiales y métodos. Se evaluó la información de los registros de población de Bucaramanga, Cali, 
Pasto y Manizales. La exhaustividad se analizó mediante las razones de mortalidad, incidencia y su 
relación con la supervivencia. La validez se estableció con la descripción de los casos verificados 
morfológicamente y los registrados en certificados de defunción. Finalmente, se describieron las 
inconsistencias generadas. 
Resultados. El análisis de exhaustividad mostró un subregistro general en los registros de 
Bucaramanga y Manizales, y un subregistro para algunas localizaciones en todos los registros. El 
análisis de validez indicó un bajo uso de los certificados de defunción como fuente de información y 
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porcentajes importantes de inconsistencias entre la base de diagnóstico y la histología.
Conclusiones. La calidad de la información de los registros de población de cáncer en Colombia 
puede ser mejorada al considerar fuentes adicionales de información, el uso de software especializado 
en captura y validación, y fortalecimiento en el registro de la mortalidad en las áreas de cobertura.
Palabras clave: estadísticas vitales, neoplasias, control de calidad, recolección de datos, 
reproducibilidad de resultados, Colombia.
doi: http://dx.doi.org/10.7705/biomedica.v32i4.756
The control of malnutrition and communicable 
diseases, the increasingly ageing population, 
changes in lifestyle and exposure to occupational 
and environmental risk factors have increased the 
burden of cancer in developing countries. The World 
Health Organization has promoted the development 
of national programs aimed toward cancer control 
(1). Population-based cancer registries have major 
relevance for this purpose. They are valuable 
sources of information for estimating cancer 
burden, planning cancer care facilities, targeting 
and monitoring interventions, and setting priorities 
for cancer control and prevention (2).
The Cali Cancer Registry (CCR) is the most 
important source of descriptive epidemiology in 
Colombia and South America (3). It has been in 
continuous operation since 1962. Although the CCR 
includes only a small fraction of the incident cancer 
cases in Colombia (4),  the information therein has 
been used as the main input for estimating cancer 
incidence at the national level (5). Other regions 
in Colombia such as Antioquia, Barranquilla, 
Bucaramanga, Manizales, Cartagena, Cesar, Huila, 
and Pasto have replicated the efforts of CCR and 
have provided preliminary results (6-10).
Information generated by cancer registries must be 
comparable and reproducible in order to accomplish 
validity. At the initial stages of establishing a 
cancer registry, efforts must be made to achieve 
collection of complete and high quality data (11). 
Periodic quality evaluations must be performed to 
guarantee the reliability of data produced by cancer 
registries, particularly in developing countries with 
a scarcity of resources, facilities and training. The 
technical report published by the International 
Agency for Research on Cancer (IARC), describes 
methodologies for judging comparability and quality 
control in cancer registration (12). An updated 
methodological approach has been published 
recently in a series of two methods articles (13,14) 
and one applied research article (15). Herein, an 
updated methodological proposal of four dimensions 
are described: comparability, completeness, validity 
and timeliness.
Comparability is essential for the interpretation 
of collected data. A critical aspect is the standar-
dization of codification and collection practices. 
Completeness consists in evaluating how many of 
the incident cases are effectively recorded by the 
population-based cancer registries. Validity refers 
to the proportion of the identified cancer cases 
with a given characteristic that actually have that 
attribute. Timeliness of reporting of a cancer registry 
is also a key aspect in cancer registries (13).
Completeness can be evaluated through qualitative, 
semi-quantitative and quantitative methods. One of 
the semi-quantitative methods is generated through 
the analysis of the mortality: incidence ratio (M:I); 
this ratio compares cancer deaths with incident 
cancer cases, specifically for each localization in 
the same time period. If quality of both sources is 
good, under some specific circumstances, the M:I 
ratio will be approximately 1 – a given five-year 
survival probability in the area of the registry or in 
an area with similar conditions. Distortions in this 
ratio will suggest completion issues that can be 
easily identified from simple graphic analyses (14).
Validity can be evaluated through four groups of 
methods: reabstracting and recoding, diagnostic 
criteria methods (histological verification, and death 
certificate only), missing information analyses, 
and internal consistency methods. Reabstracting 
and recoding is used to evaluate the concordance 
between collectors and between the collectors 
and the original data sources. Diagnostic criteria 
methods are performed through the percentage 
of cases morphologically verified and categorized 
by sex and site, as well as the proportion of 
cases identified by death certificates only. Missing 
information analyses describe the percentage of ill-
defined sites, age unknown, and unknown basis of 
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diagnosis (13). Internal consistency evaluation is 
established by the description of errors identified 
through a standardized validation program (16).
In Colombia, two studies of cancer registries have 
been performed. The first one evaluated twelve 
institution-based cancer registries and considered 
six domains: human, technological, logistical 
and political resources, quality of the information 
and information diffusion (17). The second study 
considered eight population-based cancer registries 
that evaluated coverage of information sources, 
information validity, quality assurance, comparability 
and sustainability (Pontificia Universidad Javeriana. 
Memorias del Primer Congreso Nacional de Salud 
Pública. Evaluación de los registros poblacionales 
de cáncer en Colombia. Bogotá: Facultad de Ciencias 
Económicas y Administrativas; 2006). However, 
no study has evaluated the quality of information 
collected in the databases of these registries.
The aim of the current study is to provide an 
evaluation of some aspects related to validity and 
completeness of the information collected by four 
population-based cancer registries in Colombia 
[Bucaramanga Cancer Registry (BCR), Cali Cancer 
Registry (CCR), Manizales Cancer Registry (MCR), 
and Pasto Cancer Registry (PCR)]. These four 
registries are among the seven currently active in 
Colombia, and they have produced updated cancer 
information for a period of at least five years. 
The information generated herein will be used in 
taking decisions for the inclusion of the information 
provided by these four population-based cancer 
registries, in the validation and estimation processes 
used in generating cancer incidence estimations in 
Colombia.
Materials and methods
Sources of information
Official databases of the BCR (2000-2005), the 
MCR (2002-2006), and the PCR (1998-2002) 
were obtained. Incidence data and consistency 
indicators for CCR (1998-2002) were not 
processed, but obtained from published data (5). 
Only confirmed cases residing in the target area of 
the cancer registry were included in the incidence 
analyses. The IARCcrgTools software was used 
to create equivalences between the International 
Classification of Diseases for Oncology, third edition 
(ICD-O 3) and the International Classification of 
Diseases, tenth edition (ICD-10). Conversion errors 
and warnings were described for each registry 
with the IARCcrgTools software (18). Cases with 
conversion errors were excluded from the analyses; 
cases with conversion warnings were reviewed but 
not excluded.
Official national mortality databases of the national 
department for vital statistics (DANE in Spanish 
for Departamento Administrativo Nacional de 
Estadística) were obtained for the respective time 
periods in each cancer registry. A complete analysis 
of mortality quality was performed as a secondary 
objective and independently published. The study 
concluded that mortality certification in Colombia 
and particularly in the population-based cancer 
registries areas has high quality standards for overall 
death and cancer death certification (19). Cancer 
deaths not reported by physicians were excluded 
from the analyses. The city of habitual residence 
was not imputed by the occurrence city, because 
imputing this information leads to an overestimation 
of deaths for two reasons: (1) because most cancer 
deaths occur in the main cities or capital cities of 
each district  and (2) because cancer patients 
are usually referred to specialized health services 
located at capital cities. Ill-defined natural deaths 
and ill-defined cancer deaths were not redistributed. 
Deaths from uterine cancer not otherwise specified 
were proportionally redistributed among deaths 
from uterine cancer in specified sites, for each 
registry and age group, using methods derived 
of probabilistic sampling (20). The traditional 
coverage correction for mortality of 79% estimated 
for Colombia (21) was not applied to the mortality 
data, because of a presumed very high mortality 
coverage in the registry areas.
M:I ratio was calculated by making use of the 
traditional groups for cancer localizations (22). Only 
deaths of people with habitual residence in the 
area of registries were considered in the M:I ratio 
calculation. The analyses were limited to cancer 
localizations with more than twelve cases registered 
in the period because lower numbers are associated 
with greatly fluctuating values that can make the 
estimates and data analyses difficult (23).
The five-year accumulated probability of survival 
was based on data from the Cancer Registry of 
Norway (24), since no local estimations of survival 
are available, and established specifically for 
each localization, considering all stages, for cases 
diagnosed in 1999-2003.
Statistical methods
Databases were consolidated in a single file with 
all the critical information required for the analysis 
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(identification number, birth date, incidence date, 
sex, topographical code, morphological code, 
tumor behavior, histological differentiation, and 
basis of diagnosis). Frequencies and percentages 
were employed to describe categorical variables. 
Completeness graphical analyses were performed 
through bivariance scatter plots. Data were 
analyzed using the SPSS software version 15.0.
Aspects described in completeness evaluation 
M:I ratio was calculated for each registry, sex and 
cancer localization. A bivariate scatter plot was 
used for graphical analysis, depicting the M:I ratio 
in the Y axis and the 1 minus 5 year cumulated 
probability of survival in the X axis. Localizations 
with M:I ratios higher than 1.6 were excluded from 
graphical analyses. A qualitative analysis of the 
graphical information was then performed.
Aspects described in validity evaluation
Percentage of cases morphologically verified, 
and death certification only cases were described 
specifically for each registry according to sex and 
localization. For each registry, the percentage of 
cases with unknown age or unknown or invalid basis 
of diagnosis were also described. Inconsistencies 
between age and birth date, age/site/histology, 
site/histology, sex/site, sex/histology, behavior/
site, behavior/histology, grade/histology and basis 
of diagnosis/histology were identified using the 
IARCcrgTools software (18).
Results
Incidence data analysis
A total of 7,590 incident cases of the BCR, 2,709 
of the PCR, and 2,785 of the MCR were analyzed. 
Access was unavailable to the CCR databases 
for analysis of the 16,660 cases reported in this 
registry; however, the CCR quality indicators were 
published previously by IARC (5). ICD-O 3 to ICD-
10 conversions demonstrated one case that was 
unable to be converted in the BCR because of an 
invalid combination of sex, localization or histology; 
45 cases were not converted in the MCR because 
they did not have valid ICD-O 3 codes; the PCR did 
not demonstrate conversion inconsistencies. Two 
conversion warnings were described for the MCR 
due to an improbable combination of behavior/site/
histology; no other conversion warnings appeared 
for the BCR or the PCR. After the conversion, 31 
cases of the BCR and 1 case of the MCR that were 
originally classified as malignant, were reclassified as 
benign or of uncertain behavior; these 32 cases were 
also excluded. No cases were excluded because of 
lack of information on habitual residence, age or sex, 
except in the CCR where 707 cases were excluded 
because of an unknown age.
Several cancer localizations were excluded from 
the analysis because fewer than twelve cases were 
recorded in the period. These included the following 
codes, according to the ICD-10: small intestine 
(C17), other and ill-defined digestive organs (C26), 
nasal cavity, middle ear and accessory sinuses 
(C30-C31), thymus, heart, mediastinum, pleura and 
other and ill-defined sites within respiratory system 
and intrathoracic organs (C37-C39), bones, joints 
and articular cartilage (C40-C41), mesothelioma 
(C45), Kaposi sarcoma (C46), peripheral nerves 
and autonomic nervous system (C47); connective, 
subcutaneous and other soft tissues (C49), eye 
and adnexa (C69), adrenal gland and other 
endocrine glands and related structures (C74-C75), 
malignant inmunoproliferative diseases (C88) and, 
multiple myeloma and plasma cell tumors (C90). 
Specifically for males breast (C50), penis (C60) 
and, other and unspecified males genital organs 
(C63) were excluded; for female sex, larynx (C32) 
and placenta (C58) were excluded.
Mortality data analysis
The total deaths analyzed were as follows:  5,355 
in Bucaramanga and its metropolitan area (2000-
2005), 2,046 in Manizales (2002-2006), 1,346 in 
Pasto (1998-2002), and 9,105 in Cali (1998-2002). 
In Bucaramanga and its metropolitan area, 5 deaths 
were excluded from the analyses because they 
were not certified by a physician, 32 more deaths 
were excluded because they were of unknown age. 
In Cali, 11 deaths were excluded because they 
were not certified by a physician and 114 more were 
excluded because they were of unknown age. In 
Manizales, only 2 deaths were excluded because 
they were of unknown age. In Pasto, 31 deaths 
were excluded because they were not certified by a 
physician, 30 more deaths were excluded because 
they were of unknown age.
Completeness analysis
The BCR demonstrated high M:I ratios for all 
localizations; however, in males unusual values 
were observed for pancreas, liver and gallbladder, 
and in females, unusual values were observed for 
liver, lung, gallbladder, stomach, esophagus and 
kidney (Table 1, figure 1a). The CCR demonstrated 
coherent values both for men and women with the 
exception of liver that showed a high M:I ratio (Table 
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1, figure 1b). The MCR showed high M:I ratios in 
general for all sites; with extreme values in men for 
liver, pancreas, esophagus, lung and leukemia; in 
women for liver, pancreas, esophagus, gallbladder, 
lung, central nervous system, and leukemia (Table 1, 
figure 1c). The PCR showed consistent values both 
in men and women for all sites, with the exception 
of several unusual values for lung, pancreas and 
liver in both sexes (Table 1, figure 1d).
Validity analysis
The analysis of cases established only from 
death certification revealed a low use of death 
certifications as a source of information in the BCR 
and the MCR. In the three registries (BCR, MCR, 
and PCR), a low percentage of morphologically 
verified cases were present for certain localizations 
such as liver, gallbladder, pancreas, lung, kidney, 
multiple myeloma and leukemia. The remaining 
localizations had, in general, a higher use of 
morphological verification (Table 2).
The validation software found one error in the 
combination of sex and localization in the BCR; in 
the MCR an error was found related to date of birth 
in relation to the date of incidence, 37 errors in the 
code of the histological type, 9 errors in the code 
of topographic localization, 32 errors in the age at 
diagnosis, and one error in the combination of sex 
and localization. No errors were found in the PCR. 
This software found also other inconsistencies. The 
most frequent was related to basis of diagnosis and 
histology, followed by localization and histology. 
The registry with the lowest inconsistencies was 
the BCR.  The MCR and the PCR exhibited similar 
values for inconsistencies (Table 3).
Discussion
This is the first data quality evaluation based on 
the information provided by population-based 
cancer registries in Colombia. The methodology 
was in accordance with the recently published 
recommendations by Bray and Parkin (13,14).  The 
current study was not as comprehensive, however, 
since it did not consider all the components 
described for data quality evaluation at population-
based cancer registries but rather was focused on 
validity and completeness. The present time was 
appropriate for evaluation since most registries 
had just produced their first consolidated results, 
and thereby provided an opportunity for improving 
processes established for collecting and registering 
cancer incident cases.
The lack of local estimates of overall survival for 
most cancer sites became a major limitation of 
Table 1. Mortality: Incidence ratios according to sex, site, and cancer registry in Colombia
Sites BCRa 2000-2005 CCRb 1998-2002 MCRc 2002-2006 PCRd 1998-2002
 Males Females Males Females Males Females Males Females
Lip, oral cavity and pharynx 0.73 0.45 0.48 0.35 0.73 0.45 0.31 0.18
Esophagus 1.18 1.37 0.87 0.76 1.18 1.37 0.74 0.58
Stomach 1.18 1.55 0.74 0.75 1.18 1.55 0.61 0.65
Colon, rectum, anus 0.72 0.72 0.57 0.59 0.72 0.72 0.52 0.65
Liver 2.98 2.63 1.83 1.70 2.98 2.63 1.08 1.12
Gallbladder 1.86 1.80 0.65 0.70 1.86 1.80 0.59 0.62
Pancreas 4.46 4.09 1.11 0.99 4.46 4.09 1.12 1.67
Larynx 0.83 0.90 0.5 0.70 0.83 0.9 1.50 NAe
Lung, trachea and bronchus 2.17 2.19 0.88 0.87 2.17 2.19 1.33 1.52
Melanoma of skin 0.45 0.37 0.19 0.15 0.45 0.37 0.36 0.10
Breast  0.36  0.34  0.36  0.31
Cervix uteri  0.56  0.44  0.56  0.41
Corpus uteri  0.32  0.30  0.32  0.03
Ovary  0.85  0.47  0.85  0.55
Prostate 0.43  0.35  0.43  0.42 
Testis 0.30  0.22  0.30  0.09  
Kidney 0.95 1.26 0.47 0.39 0.95 1.26 0.54 0.75
Bladder 0.51 0.51 0.38 0.34 0.51 0.51 0.26 0.41 
Brain and central nervous system 0.93 0.90 0.69 0.70 0.93 0.90 0.87 0.79 
Thyroid 0.22 0.09 0.29 0.07 0.22 0.09 0.27 0.13
Non-Hodgkin lymphoma 0.69 0.60 0.37 0.38 0.69 0.60 0.35 0.36 
Hodgkin lymphoma 0.62 0.54 0.29 0.38 0.62 0.54 0.60 0.63
Leukemia 0.93 1.06 0.75 0.72 0.93 1.06 0.61 0.81
aBCR: Bucaramanga Cancer Registry, bCCR: Cali Cancer Registry, cMCR: Manizales Cancer Registry, dPCR: Pasto Cancer Registry, 
eNA: No data available because there were no registered cases.
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Figure 1. Mortality: Incidence ratios of aBCR, bCCR, cMCR, AND dPCR versus 1-survival
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this study, since Norway cancer survival data 
(24) cannot be directly applied to the Colombian 
populations. The graphical behavior of the M:I ratio 
in relation to 1 – survival showed that all localizations 
are very close to the diagonal line in CCR. This 
indicated that Norway survival was an appropriate 
surrogate for local survival.  However, the data 
were increasingly more distant in the PCR, BCR 
and MCR. This was particularly true for the female 
data, suggesting differences in the recording of the 
cancer incidence for females. The high M:I ratio put 
in evidence a lack of identification of cancer cases 
from death certificates. These very high M:I ratios 
may also be associated with misclassifications 
in the habitual residence of the deceased, since 
most cancer cases occurring in small, distant 
towns are referred to district capitals.  Therefore, 
deaths occurring in district capitals may be certified 
as people habitually residing in the district capital 
when this is not in fact the case. Consequently, 
a formal definition of habitual residence must be 
implemented for death certification in areas where 
population-based cancer registries are established. 
Physicians in charge of death certification in these 
areas must be duly trained in the proper filling of 
death certificates (25).
Because all of the registries, including CCR, 
demonstrated high M:I ratios for liver, pancreas 
Table 2. Indices of data quality, according to sex, site, and cancer registry in Colombia.
Sites BCRa 2000-2005 CCRb 1998-2002 * MCRc 2002-2006 PCRd 1998-2002
 Males Females Males Females Males Females Males Females
 MVe DCOf MV DCO MV DCO MV DCO MV DCO MV DCO MV DCO MV DCO
Lip, oral cavity and pharynx 97.3 0.0 98.7 0.0 86.7 3.9 92.0 0.6 100.0 0.0 96.7 0.0 75.0 18.8 82.4 5.9
Esophagus 97.2 0.0 100.0 0.0 79.5 9.8 79.5 10.3 85.7 0.0 94.7 0.0 80.0 17.1 83.3 16.7
Stomach 97.6 0.0 95.4 0.0 76.7 10.1 71.5 15.4 97.2 0.0 93.2 0.0 81.0 13.9 70.9 20.6 
Colon, rectum, anus 98.7 0.0 98.1 0.0 84.1 6.6 83.0 7.1 95.2 0.0 96.2 0.0 88.6 6.8 75.4 10.8 
Liver 97.7 0.0 94.7 0.0 66.7 8.6 68.5 8.9 66.7 16.7 52.9 0.0 53.8 30.8 28.0 48.0
Gallbladder 95.2 0.0 100.0 0.0     69.2 7.7 70.0 0.0 76.5 11.8 61.7 25.0
Pancreas 76.9 0.0 91.3 0.0 36.9 14.9 35.7 21.4 50.0 0.0 46.2 0.0 41.2 23.5 23.8 38.1
Larynx 100.0 0.0 100.0 0.0 85.1 3.3 68.1 8.5 100.0 0.0 100.0 0.0 100.0 0.0 NA NAg
Lung, trachea and bronchus 79.7 0.0 78.7 0.0 55.3 12.7 56.8 13.6 73.3 1.0 82.3 0.0 45.7 23.9 64.0 32.0
Melanoma of skin 97.6 0.0 100.0 0.0 96.8 0.0 99.3 0.0 95.7 0.0 100.0 0.0 100.0 0.0 1000 0.0
Breast   98.2 0.0   92.9 2.2   91.1 0.0   89.3 4.2 
Cervix uteri   99.5 0.0   93.8 2.1   94.1 0.0   88.9 8.2 
Corpus uteri   100.0 0.0   87.8h 6.3   94.1 0.0   86.5 8.1 
Ovary   92.7 0.0   72.8 7.7   90.2 0.0   82.8 6.9 
Prostate 98.4 0.0   85.1 5.1   95.5 0.0   71.9 15.7   
Testis 97.7 0.0   93.0 0.9   96.4 0.0   100.0 0.0   
Kidney 92.5 0.0 94.7 0.0 80.6 2.2 79.5 6.0 88.9 0.0 86.4 0.0 69.2 7.7 75.0 8.3 
Bladder 92.8 0.0 95.3 0.0 88.7 2.0 83.5 3.7 95.1 0.0 93.8 0.0 82.9 8.6 82.4 11.8 
Brain and central nervous 
system 92.0 0.0 90.1 0.0 78.8 2.8 76.1 4.8 80.6 0.0 78.6 7.1 73.9 4.3 58.3 33.3 
Thyroid 92.7 0.0 95.0 0.0 89.4 2.4 97.8 0.0 91.7 0.0 81.8 0.0 100.0 0.0 90.1 2.8 
Non-Hodgkin lymphoma 97.2 0.0 95.4 0.0 90.5j 0.4 93.0 0.6 95.9 0.0 93.9 0.0 87.7 5.3 87.3 3.6 
Hodgkin lymphoma 93.1 0.0 91.7 0.0     100.0 0.0 100.0 0.0 86.7 0.0 100.0 0.0 
Leukemia 68.5 0.0 70.3 0.0 91.1 0.3 90.0 1.7 71.4 0.0 70.0 0.0 17.1 7.3 40.5 16.2 
Total 94.5 0.0 94.9 0.0 79.2 6.3 82.9 6.0 91.5 0.3 90.2 0.1 77.7 11.1 81.2 10.8
aBCR: Bucaramanga Cancer Registry; bCCR: Cali Cancer Registry, *Source: Cancer Incidence in Five Continents IX; cMCR: Manizales Cancer 
Registry; dPCR: Pasto Cancer Registry; eMV: Morphologically verified; fDCO: Death certificate only; gNA: No data available because there were no 
registered cases; hCorpus uteri includes C54-C55 in CCR; jNon-Hodgkin Lymphoma includes Non-Hodgkin lymphoma and Hodgkin lymphoma in 
CCR.
Table 3. Percentage of consistencies according to cancer registry in Colombia.
Consistency BCRa MCRb PCRc
 (2000-2005) (2002-2006) (1998-2002) 
Age/site/histology 99.7 99.5 99.9 
Basis of diagnosis/histology 99.6 97.6 92.0 
Site/histology 99.8 99.1 99.3 
Behavior/histology 100.0 99.9 100.0
aBCR: Bucaramanga Cancer Registry, bMCR: Manizales Cancer Registry, cPCR: Pasto Cancer Registry
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and lung, we hypothesized a systematic error in 
death certification. It is possible that some of the 
metastatic liver and lung tumors could have been 
erroneously registered as primary tumors of liver 
and lung in death certificates. Other reasons for the 
high M:I ratios observed for esophagus, gallbladder 
and leukemia may be systematic errors in incidence 
data collection where relevant data sources are 
omitted such as endoscopic centers, general 
hospitals, or hematological clinics. Strategies 
such as establishing personal contact with general 
surgeons, internists or hematologists working in 
the area with the purpose of reporting cases that 
probably will not be registered by the traditional data 
sources have been successfully implemented (26). 
Electronic media for case report will also enhance 
the opportunity and the completeness of the 
population-based cancer registries in Colombia.
The analysis of the diagnostic confirmation method 
demonstrated that only CCR and PCR use death 
registries as a source of information. This finding 
confirmed the hypothesis of a lowered recording of 
cancer incidence in highly lethal cancers such as 
liver, gallbladder, pancreas, lung, multiple myeloma 
and leukemia. Population-based cancer registries 
in Colombia are aware of this problem (7); in fact, 
the MCR started to include the information from 
death certificates immediately after the conclusion 
of the current study. Exploration of alternatives 
is recommended that are aimed to facilitate the 
direct or indirect access to mortality databases. 
Other countries with similar difficulties have achieved 
unrestricted access to mortality databases and have 
successfully accomplished the inclusion of mortality 
information in cancer registries (26,27). In this regard, 
making use of the national mortality databases (not 
local mortality databases) is to be commended, 
because a sizeable percentage of cases are recorded 
in a city different from the city of residence.
The percentage of cases with morphologically 
verified cases and with known age was satisfactory 
in all registries, although it signalled the very low 
percentage of cases with unknown age and the 
high percentage of morphologically verified cases. 
This may be due to an incomplete search of cases, 
probably based solely in pathology centers; this 
may also be the explanation for the high M:I ratios. 
Validity analysis showed a low but persistent 
percentage of inconsistencies between the basis of 
diagnosis and the histological type; it demonstrated 
the lack of software capable of fully validating 
the data input. The experience of CCR and the 
institutional-based cancer registry of the Instituto 
Nacional de Cancerología may help to develop 
the activities of the younger registries. The PCR 
demonstrated better validity indicators, reflecting 
the assistance provided by the CCR.
Future studies must verify that a completely depurated 
database is obtained from registries, because some 
validation processes that are routinely applied to 
the information collected by the registries cannot be 
applied to the databases.  This situation will create 
an underestimation of the data quality.
The extensive effort required to collect cancer 
incidence information in developing countries must 
continue, but quality of the collected data must be 
evaluated periodically and systematically in order 
to achieve high quality standards that permit the 
unrestricted use of the information provided by 
young registries.  If this is not accomplished, the 
information will continue to be collected at an 
enormous expense, but without a clear impact on 
cancer information due to low quality standards. 
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